These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 30397150)
1. Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats. Fong LY; Jing R; Smalley KJ; Wang ZX; Taccioli C; Fan S; Chen H; Alder H; Huebner K; Farber JL; Fiehn O; Croce CM Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11091-E11100. PubMed ID: 30397150 [TBL] [Abstract][Full Text] [Related]
2. Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model. Costello LC; Franklin RB; Zou J; Feng P; Bok R; Swanson MG; Kurhanewicz J Cancer Biol Ther; 2011 Dec; 12(12):1078-84. PubMed ID: 22156800 [TBL] [Abstract][Full Text] [Related]
4. hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1). Zou J; Milon BC; Desouki MM; Costello LC; Franklin RB Prostate; 2011 Oct; 71(14):1518-24. PubMed ID: 21360563 [TBL] [Abstract][Full Text] [Related]
5. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Desouki MM; Geradts J; Milon B; Franklin RB; Costello LC Mol Cancer; 2007 Jun; 6():37. PubMed ID: 17550612 [TBL] [Abstract][Full Text] [Related]
6. The miR-183 family cluster alters zinc homeostasis in benign prostate cells, organoids and prostate cancer xenografts. Dambal S; Baumann B; McCray T; Williams L; Richards Z; Deaton R; Prins GS; Nonn L Sci Rep; 2017 Aug; 7(1):7704. PubMed ID: 28794468 [TBL] [Abstract][Full Text] [Related]
7. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues. Wei H; Desouki MM; Lin S; Xiao D; Franklin RB; Feng P Mol Cancer; 2008 Jan; 7():7. PubMed ID: 18208603 [TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer. Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690 [TBL] [Abstract][Full Text] [Related]
11. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Costello LC; Franklin RB Mol Cancer; 2006 May; 5():17. PubMed ID: 16700911 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Singh KK; Desouki MM; Franklin RB; Costello LC Mol Cancer; 2006 Apr; 5():14. PubMed ID: 16595004 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC Carcinogenesis; 2001 Jun; 22(6):965-73. PubMed ID: 11375906 [TBL] [Abstract][Full Text] [Related]
14. Tissue-specific alterations in zinc transporter expression in intestine and liver reflect a threshold for homeostatic compensation during dietary zinc deficiency in weanling rats. Jou MY; Hall AG; Philipps AF; Kelleher SL; Lönnerdal B J Nutr; 2009 May; 139(5):835-41. PubMed ID: 19297427 [TBL] [Abstract][Full Text] [Related]
15. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency. Fong LY; Taccioli C; Jing R; Smalley KJ; Alder H; Jiang Y; Fadda P; Farber JL; Croce CM Oncotarget; 2016 Mar; 7(10):10723-38. PubMed ID: 26918602 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of drs mRNA in human prostate carcinomas. Kim CJ; Shimakage M; Kushima R; Mukaisho K; Shinka T; Okada Y; Inoue H Hum Pathol; 2003 Jul; 34(7):654-7. PubMed ID: 12874760 [TBL] [Abstract][Full Text] [Related]
18. N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1. He G; Li M; Fang L; Xu L; Huang X; Zheng L; Yang L; Luo W; Cai Y; Ma W; Liang C; Yin Y Oncol Rep; 2020 Nov; 44(5):2265-2274. PubMed ID: 33000273 [TBL] [Abstract][Full Text] [Related]
19. HMGA2 expression in a canine model of prostate cancer. Winkler S; Murua Escobar H; Meyer B; Simon D; Eberle N; Baumgartner W; Loeschke S; Nolte I; Bullerdiek J Cancer Genet Cytogenet; 2007 Sep; 177(2):98-102. PubMed ID: 17854662 [TBL] [Abstract][Full Text] [Related]
20. A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression. Chang C; Liu J; He W; Qu M; Huang X; Deng Y; Shen L; Zhao X; Guo H; Jiang J; Fu XY; Huang R; Zhang D; Yan J Oncogene; 2018 Jan; 37(4):415-426. PubMed ID: 28967902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]